RPMGX
Price
$97.30
Change
-$0.03 (-0.03%)
Updated
Sep 18 closing price
Net Assets
20.82B
SFMIX
Price
$38.04
Change
-$0.01 (-0.03%)
Updated
Sep 18 closing price
Net Assets
779.71M
Interact to see
Advertisement

RPMGX vs SFMIX

RPMGX vs SFMIX Comparison Chart in %
View a ticker or compare two or three
VS
RPMGX vs. SFMIX commentary
Sep 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPMGX is a Hold and SFMIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 20.8B vs. SFMIX (780M). RPMGX (0.00) and SFMIX (0.00) have matching dividends . RPMGX was incepted earlier than SFMIX: RPMGX (34 years) vs SFMIX (20 years). SFMIX (0.92) is less costly to investors than RPMGX (0.77). SFMIX is a more actively managed with annual turnover of: 51.00 vs. RPMGX (31.50). RPMGX has a lower initial minimum investment than SFMIX: RPMGX (2500) vs SFMIX (250000). RPMGX annual gain was more profitable for investors over the last year : -5.63 vs. SFMIX (-13.57). SFMIX return over 5 years is better than : -8.51 vs. RPMGX (-24.20).
RPMGXSFMIXRPMGX / SFMIX
Total Expense Ratio0.770.8987%
Annual Report Gross Expense Ratio0.770.9284%
Fund Existence34 years20 years-
Gain YTD0.0629.8151%
Front LoadN/AN/A-
Min. Initial Investment25002500001%
Min. Initial Investment IRAN/AN/A-
Net Assets20.8B780M2,667%
Annual Yield % from dividends0.000.00-
Returns for 1 year-5.63-13.5742%
Returns for 3 years-0.1920.80-1%
Returns for 5 years-24.20-8.51284%
Returns for 10 years27.75101.0527%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGOAX11.150.01
+0.09%
Goldman Sachs Mid Cap Growth A
JOHAX29.76-0.01
-0.03%
JOHCM International Select Investor
PRHSX94.44-0.31
-0.33%
T. Rowe Price Health Sciences
THMEX16.85-0.07
-0.41%
CCT Thematic Equity Institutional
BRSYX16.90-0.09
-0.53%
MFS Blended Research Small Cap Eq R6